ArticleDrugs in R&D2021

Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration.

John Dodd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.